|
⚲
|
| Juvaris Bio Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001347758 |
| Sale | 2009-09-11 ($25.1 M Offered, $15.1 M Sold) |
| Fund | |
| Phone | 6506978828 |
| Address | 866 Malcolm Road, Suite 100 Burlingame, 94010 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Kimberlee Gonzaga | |
| Michael Ross | |
| Thomas Monath | |
| Grant Pickering | |
| Lewis Williams | |
| Carol Brosgart |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
101Ventures Fintech-Oxy 1, LLC
✚
|
0.0 | |
|
1052 Partners, LLC
✚
|
0.0 | |
|
105 W First Street, L.L.C.
✚
|
0.0 | |
|
10K Lakes Fund I LP
✚
|
0.0 | |
|
1100 15th Street Investors LLC
✚
|
0.0 | |
|
1180 E Street Investors LLC
✚
|
0.0 | |
|
11810 Algonquin Partners, LLC
✚
|
0.0 | |
|
11 Capital Offshore Fund Ltd
✚
|
0.0 | |
|
11 Capital Onshore Fund LP
✚
|
0.0 | |
|
Cicco Susan
✚
|
0.0 |